Disease severity as a predictor of outcome in scleroderma

Lancet. 2002 Jan 26;359(9303):277-9. doi: 10.1016/S0140-6736(02)07535-9.
No abstract available

MeSH terms

  • Autoantibodies / blood
  • Cytokines / blood
  • Follow-Up Studies
  • Humans
  • Predictive Value of Tests
  • Scleroderma, Systemic / diagnosis*
  • Scleroderma, Systemic / mortality
  • Survival Rate

Substances

  • Autoantibodies
  • Cytokines